Anticancer perspective of 6-shogaol: anticancer properties, mechanism of action, synergism and delivery system

被引:12
|
作者
Jia, Yaoxia [1 ,3 ]
Li, Xing [2 ]
Meng, Xiangqi [1 ,3 ]
Lei, Jinjie [1 ,3 ]
Xia, Yangmiao [1 ,3 ]
Yu, Lingying [1 ,3 ]
机构
[1] Chengdu Univ Tradit Chinese Med, Coll Pharm, 1166 Liutai Ave, Chengdu 611137, Peoples R China
[2] Jianyang Chinese Med Hosp, Chengdu 641400, Peoples R China
[3] State Key Lab Southwestern Chinese Med Resources, Chengdu, Peoples R China
关键词
Ginger; 6-Shogaol; Anti-cancer; Mechanism; Toxicity; Synergy; Delivery system; NF-KAPPA-B; CELL-CYCLE ARREST; CYSTEINE-CONJUGATED METABOLITE; CANCER-CELLS; THERAPEUTIC APPROACH; INHIBITS GROWTH; GINGER; APOPTOSIS; BREAST; 6-GINGEROL;
D O I
10.1186/s13020-023-00839-0
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Cancer is a malignant disease that has plagued human beings all the time, but the treatment effect of commonly used anticancer drugs in clinical practice is not ideal by reason of their drug tolerance and Strong adverse reactions to patients. Therefore, it is imperative to find effective and low-toxic anticancer drugs. Many research works have shown that natural products in Chinese herbal medicine have great anticancer potential, such as 6-shogaol, a monomer composition obtained from Chinese herbal ginger, which has been confirmed by numerous in vitro or vivo studies to be an excellent anti-cancer active substance. In addition, most notably, 6-shogaol has different selectivity for normal and cancer cells during treatment, which makes it valuable for further research and clinical development. Therefore, this review focus on the anti-cancer attributes, the mechanism and the regulation of related signaling pathways of 6-shogaol. In addition, its synergy with commonly used anticancer drugs, potential drug delivery systems and prospects for future research are discussed. This is the first review to comprehensively summarize the anti-cancer mechanism of 6-shogaol, hoping to provide a theoretical basis and guiding significance for future anti-cancer research and clinical development of 6-shogaol.
引用
收藏
页数:21
相关论文
共 50 条
  • [21] Anticancer effect of Howiinol A and its mechanism of action
    Xu, CX
    He, JH
    JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 1999, 2 (01) : 1 - 19
  • [22] Texanes -: Anticancer drug with unique mechanism of action
    Borek-Dohalská, L
    Stiborová, M
    CHEMICKE LISTY, 2000, 94 (04): : 226 - 229
  • [23] SURAMIN - AN ANTICANCER DRUG WITH A UNIQUE MECHANISM OF ACTION
    STEIN, CA
    LAROCCA, RV
    THOMAS, R
    MCATEE, N
    MYERS, CE
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (04) : 499 - 508
  • [24] Optimization protocol for the extraction of 6-gingerol and 6-shogaol from Zingiber officinale var. rubrum Theilade and improving antioxidant and anticancer activity using response surface methodology
    Ali Ghasemzadeh
    Hawa Z.E. Jaafar
    Asmah Rahmat
    BMC Complementary and Alternative Medicine, 15
  • [25] Anticancer properties and mechanism insights of α-hederin
    Belmehdi, Omar
    Taha, Douae
    Abrini, Jamal
    Ming, Long Chiau
    Khalid, Asaad
    Abdalla, Ashraf N.
    Algarni, Alanood S.
    Hermansyah, Andi
    Bouyahya, Abdelhakim
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 165
  • [26] Milk Exosomes: Perspective Agents for Anticancer Drug Delivery
    Sedykh, Sergey
    Kuleshova, Anna
    Nevinsky, Georgy
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (18) : 1 - 16
  • [27] Optimization protocol for the extraction of 6-gingerol and 6-shogaol from Zingiber officinale var. rubrum Theilade and improving antioxidant and anticancer activity using response surface methodology
    Ghasemzadeh, Ali
    Jaafar, Hawa Z. E.
    Rahmat, Asmah
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 15
  • [28] Targeted proapoptotic anticancer drug delivery system
    Chandna, Pooja
    Saad, Maha
    Wang, Yang
    Ber, Elizabeth
    Khandare, Jayant
    Vetcher, Alexandre A.
    Soldatenkov, Viatcheslav A.
    Minko, Tamara
    MOLECULAR PHARMACEUTICS, 2007, 4 (05) : 668 - 678
  • [29] Nanocrystals: An Approachable Delivery System for Anticancer Therapeutics
    Khairnar, Pooja
    Handa, Mayank
    Shukla, Rahul
    CURRENT DRUG METABOLISM, 2022, 23 (08) : 603 - 615
  • [30] Potential Anticancer Properties and Mechanisms of Action of Formononetin
    Jiang, Dongjun
    Rasul, Azhar
    Batool, Rabia
    Sarfraz, Iqra
    Hussain, Ghulam
    Tahir, Muhammad Mateen
    Qin, Tian
    Selamoglu, Zeliha
    Ali, Muhammad
    Li, Jiang
    Li, Xiaomeng
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019